Sanfilippo B Enzyme Replacement Therapy M041 Can Get Into Cells

Sanfilippo B Enzyme Replacement Therapy M041 Can Get Into Cells

303473

Sanfilippo B Enzyme Replacement Therapy M041 Can Get Into Cells

M041, an enzyme replacement therapy M6P Therapeutics (M6PT) is developing for Sanfilippo syndrome type B, can effectively be transported into cells, proof-of-concept preclinical data show. With data showing such “increased efficiency … M041 is a potential novel recombinant enzyme therapy for Sanfilippo B syndrome,” M6PT said in a press release. The results were presented at the 16th Annual International Symposium of MPS and Related Diseases (MPS 2021), in a poster titled “Recombinant human NAGLU with…

You must be logged in to read/download the full post.